KRAS and pancreatic ductal adenocarcinoma: In particular, the frequencies of KRAS mutations are high in pancreatic ductal adenocarcinoma (PDAC; ~ 90%), colorectal cancer (CRC; ~ 45%), and non-small cell lung cancer (NSCLC; ~ 30%) [1].